CTOs on the Move

Kofax

www.kofax.com

 
Kofax is a leading provider of smart process applications that simplify and transform the First Mile™ of customer engagement. Because loyalty can be won or lost within the first few moments of any transaction, that means focusing on the point of engagement between our clients and their customers. Efficiencies at that critical juncture drive customer loyalty, improved service, market advantage, and cost reductions. Kofax helps organizations become more customer-centric, and we are searching for employees who share our passion. The caliber and diversity of our people are critical to our success because these qualities are vital for maintaining a strong, innovative ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million
  • www.kofax.com
  • 15211 Laguna Canyon Road
    Irvine, CA USA 92618
  • Phone: 949.783.1000

Executives

Name Title Contact Details
Anthony Macciola
 Chief Technology Officer Profile

Similar Companies

Moldex3D

Moldex3D is a Novi, MI-based company in the Software and Internet sector.

JTI Inc

JTI Inc is a Virginia Beach, VA-based company in the Software and Internet sector.

Zbshareware Lab

Zbshareware Lab is a Eden Prairie, MN-based company in the Software and Internet sector.

Ketch

Join us on our mission to automate privacy compliance, control and secure customer data and help businesses build regulation proof software, faster.

Cypher Genomics

Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing. The proprietary, automated genomic interpretation platform allows clinical laboratories to tune Cypher Genomics' market leading sensitivity and specificity profiles to develop molecular tests for diagnostic and prognostic use, and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies. Through Mantis™, the genome interpretation software as a service offering, and Coral™, a biomarker discovery service, Cypher Genomics can improve health care and reduce costs by facilitating improved diagnostic accuracy and earlier interventions, optimizing therapeutic approaches and reducing adverse drug reactions. The gap between the ability to generate whole genome sequences at scale and the primarily manual process of interpretation to date creates a significant unmet need that is well served by the Cypher Genomics solution.